TY - JOUR
T1 - Machine Learning for Automated Quality Evaluation in Pharmaceutical Manufacturing of Emulsions
AU - Unnikrishnan, Saritha
AU - Donovan, John
AU - Macpherson, Russell
AU - Tormey, David
N1 - Publisher Copyright:
© 2019, Springer Science+Business Media, LLC, part of Springer Nature.
PY - 2020/9/1
Y1 - 2020/9/1
N2 - Purpose: In pharmaceutical industries, the quality assessment of emulsions is typically based on subjective examination of these samples under the microscope by trained analysts. The major drawbacks of such manual quality assessment include inter-observer variability, intra-observer variability, lack of speed and poor accuracy. In order to address these challenges, an automated approach, based on machine vision and machine learning, is investigated in this study. Methods: Micrographs, obtained during an emulsification process, are classified into four quality-based categories named TAMU (target, acceptable, marginal and unacceptable). A machine learning approach using principal component–based discriminant analysis is employed in this study for the classification. This approach is compared with manual classification results obtained for the same set of micrographs using attribute agreement analysis, which is a methodology of assessing the accuracy and precision of an evaluation system. Results: The automated approach is demonstrated to be repeatable, 40% more accurate compared to the least performing analyst and 10% more accurate than the best performing analyst. The results show that the automated classification is superior to manual classification of micrographs with respect to speed (180 times faster), greater accuracy and repeatability. Conclusions: The automated approach, implemented as a soft sensor, integrated with real-time image acquisition can be applied for in situ process monitoring of emulsions. The real-time approach can be used to predict the instantaneous product quality as well as optimum process time required to achieve the desirable droplet characteristics, which will avoid over-processing and wastage of resources in pharmaceutical industries.
AB - Purpose: In pharmaceutical industries, the quality assessment of emulsions is typically based on subjective examination of these samples under the microscope by trained analysts. The major drawbacks of such manual quality assessment include inter-observer variability, intra-observer variability, lack of speed and poor accuracy. In order to address these challenges, an automated approach, based on machine vision and machine learning, is investigated in this study. Methods: Micrographs, obtained during an emulsification process, are classified into four quality-based categories named TAMU (target, acceptable, marginal and unacceptable). A machine learning approach using principal component–based discriminant analysis is employed in this study for the classification. This approach is compared with manual classification results obtained for the same set of micrographs using attribute agreement analysis, which is a methodology of assessing the accuracy and precision of an evaluation system. Results: The automated approach is demonstrated to be repeatable, 40% more accurate compared to the least performing analyst and 10% more accurate than the best performing analyst. The results show that the automated classification is superior to manual classification of micrographs with respect to speed (180 times faster), greater accuracy and repeatability. Conclusions: The automated approach, implemented as a soft sensor, integrated with real-time image acquisition can be applied for in situ process monitoring of emulsions. The real-time approach can be used to predict the instantaneous product quality as well as optimum process time required to achieve the desirable droplet characteristics, which will avoid over-processing and wastage of resources in pharmaceutical industries.
KW - Attribute agreement analysis
KW - Automated quality evaluation
KW - Emulsion processing
KW - Machine learning
KW - Machine vision
KW - Manual assessment
UR - http://www.scopus.com/inward/record.url?scp=85064635643&partnerID=8YFLogxK
U2 - 10.1007/s12247-019-09390-8
DO - 10.1007/s12247-019-09390-8
M3 - Article
AN - SCOPUS:85064635643
SN - 1872-5120
VL - 15
SP - 392
EP - 403
JO - Journal of Pharmaceutical Innovation
JF - Journal of Pharmaceutical Innovation
IS - 3
ER -